angiotensin II receptor blockers (candesartan), as sustitute of non tolered angiotensin converting enzyme inhibitors
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2003 Sep 6;362(9386):772-6 Randomized Controlled Trial, Multicenter Study
IN heart failure, chronic, systolic The Use of
angiotensin II receptor blockers (candesartan), as sustitute of non tolered angiotensin converting enzyme inhibitors
As Treatment, Chronic
Is better Than
placebo
To reducing combined outcome cardio-vascular death or hospital admission for heart failure (33% in intv. / 40% in cont. in 34 months)